NCT00044993View on ClinicalTrials.gov

Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2002

Study Completion Date

August 31, 2004

Conditions
Breast Cancer
Interventions
BIOLOGICAL

Ad5CMV-p53 gene

DRUG

docetaxel

DRUG

doxorubicin hydrochloride

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (1)

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Introgen Therapeutics

INDUSTRY